target="_blank" rel="nofollow" href="#ulink_ce08ccb1-6923-54f2-8ad8-b9f376eefb3b">21Carlier M, Dumoulin A, Janssen A, Picavet S, Vanthuyne S, Van Eynde R, et al: Comparison of different equations to assess glomerular filtration in critically ill patients. Intensive Care Med 2015;41:427–435.
22Chen S: Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol 2013;24:877–888.
23O’Sullivan ED, Doyle A: The clinical utility of kinetic glomerular filtration rate. Clin Kidney J 2017;10:202–208.
24Kellum JA: Why are patients still getting and dying from acute kidney injury? Curr Opin Crit Care 2016;22:513–519.
25McIlroy DR, Argenziano M, Farkas D, Umann T, Sladen RN: Incorporating oliguria into the diagnostic criteria for acute kidney injury after on-pump cardiac surgery: impact on incidence and outcomes. J Cardiothorac Vasc Anesth 2013;27:1145–1152.
26Schetz M, Schortgen F: Ten shortcomings of the current definition of AKI. Intensive Care Med 2017;43:911–913.
27Schetz M, Gunst J, Van den Berghe G: The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU. Intensive Care Med 2014;40:1709–1717.
28Pickering JW, Endre ZH: Bench to bedside: the next steps for biomarkers in acute kidney injury. Am J Physiol Renal Physiol 2016;311:F717–F721.
29McIlroy DR, Wagener G, Lee HT: Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 2010;112:998–1004.
30Meersch M, Schmidt C, Hoffmeier A, van Aken H, Wempe C, Gerss J, et al: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017;43:1551–1561.
31Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007;71:1028–1035.
32Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, Goldstein SL: AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol 2015;10:554–561.
33Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL; AWARE Investigators: Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 2017;376:11–20.
34Ricci Z, Ronco C: Neonatal RIFLE. Nephrol Dial Transplant 2013;28:2211–2214.
35Koralkar R, Ambalavanan N, Levitan EB, McGwin G, Goldstein S, Askenazi D: Acute kidney injury reduces survival in very low birth weight infants. Pediatr Res 2011;69:354–358.
36Gupta C, Massaro AN, Ray PE: A new approach to define acute kidney injury in term newborns with hypoxic ischemic encephalopathy. Pediatr Nephrol 2016;31:1167–1178.
37Zappitelli M, Ambalavanan N, Askenazi DJ, Moxey-Mims MM, Kimmel PL, Star RA, et al: Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop. Pediatr Res 2017;82:569–573.
38Jetton JG, Selewski JG, David T, et al: Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health 2017;1:184–194.
Zaccaria Ricci, MD
Department of Cardiology, Cardiac Surgery, and Pediatric Cardiac Intensive Care Unit
Bambino Gesù Children’s Hospital, IRCCS
Piazza S. Onofrio 4
IT–00165 Rome (Italy)
E-Mail [email protected]
Ding X, Rosner MH, Ronco C (eds): Acute Kidney Injury – Basic Research and Clinical Practice. Contrib Nephrol. Basel, Karger, 2018, vol 193, pp 13–20 (DOI: 10.1159/000484959)
______________________
Acute Kidney Injury Risk Assessment
Wuhua Jianga–e · Jiarui Xua–e · Bo Shena–e · Yimei Wanga–e · Jie Tenga–e · Xiaoqiang Dinga–e
aDepartment of Nephrology, Zhongshan Hospital, Fudan University, bShanghai Medical Center of Kidney Disease, cShanghai Institute of Kidney and Dialysis, dShanghai Key Laboratory of Kidney and Blood Purification, and eHemodialysis Quality Control Center of Shanghai, Shanghai, China
______________________
Abstract
Acute kidney injury (AKI) is a common global health challenge, affecting patient morbidity adversely and resulting in an estimated 1.4 million deaths per year. Since the International Society of Nephrology proposed a goal of eliminating preventable deaths from AKI by 2025, implementation of this program remains far from optimistic not only because of the lack of resources but also because of the scarce data addressing the epidemiology and causes of AKI, especially in developing countries, the relative insufficient health care resources to diagnose and treat AKI, and the delayed awareness of the impact of AKI on patient outcomes. Therefore, quality measures of the AKI management are crucial to ensure a better outcome achieved with integrated resource.
© 2018 S. Karger AG, Basel
Introduction
Acute kidney injury (AKI) is defined by a rapid deterioration in kidney function resulting in reduced clearance of excess fluid, electrolytes and toxins. It is remarkably prevalent among hospitalized patients and is associated with adverse outcomes such as prolonged length of stay and increased mortality [1]. Previous studies reported AKI incidence ranges between 5 and 7% of hospitalized patients [2–4], and resulting in a 1.7–6.9-fold increased risk of hospital
